Clinical Trials Browser

INDUSTRY × Interventional × Blood Specimen Collection × Clear all

NCT06274515 2026-03-09

REMERGE

Phase 4 Recruiting

Breast Neoplasms

NCT06492122 2026-01-29

ProTACT

Phase 1 Recruiting

Metastatic Castration-resistant Prostate Cancer

NCT04875871 2025-05-11

PARTICLE-PATHY

Phase NA Terminated

Neoplasms

NCT06703632 2025-02-27

MS-Prevecol

Phase NA Recruiting

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT02274662 2025-01-16

Expanded Access Protocol Thymus Transplantation

Phase 4 Completed

11 enrolled 10 charts

Thymic aplasia, Immunologic Deficiency Syndromes

NCT06033183 2024-11-22

FOCUSO

Phase NA Recruiting

Neoplasms, Radiation Injuries

NCT05133128 2024-02-22

IMMUNOPBMC

Phase NA Terminated

Neoplasms

NCT04180176 2024-01-17

PCG

Phase 4 Completed

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

NCT03860207 2023-09-13

Study of the Safety and Efficacy of Humanized 3F8 Bispecific Antibody (Hu3F8-BsAb) in Patients With Relapsed/Refractory Neuroblastoma, Osteosarcoma and Other Solid Tumor Cancers

Phase 1/2 Terminated

12 enrolled 15 charts

Neuroblastoma, Osteosarcoma

NCT03371420 2023-04-18

PET Imaging of Subjects Using 124I-PU-AD

Phase EARLY_PHASE1 Terminated

LymphoidPlasma cell

Alzheimer Disease, Lymphoma, Neoplasms, Plasma Cell

NCT04515043 2021-06-01

EXPLORATORY STUDY Addendum to INVAC1-CT-101 (NCT02301754)

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT03355820 2020-11-19

A Follow-up Extension Study to Evaluate the Persistence of Immune Response to GSK Biologicals' HPV Vaccine in Healthy Chinese Female Subjects Who Received Three Doses of the Vaccine in the HPV-058 Study

Phase 3 Completed

228 enrolled 11 charts

Uterine Cervical Dysplasia

NCT00947115 2020-10-30

Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects

Phase 3 Completed

525 enrolled 24 charts

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT00685750 2019-06-20

Expression Analysis of Specific Markers in Non-small Cell Lung Cancer or Melanoma

Phase NA Terminated

88 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung

NCT00518336 2016-12-09

Follow-up Study to Evaluate the Long-term Efficacy of the HPV Vaccine (580299) in Healthy Young Adult Women in Brazil

Phase 2 Completed

433 enrolled 66 charts

Papillomavirus Infections

NCT01521780 2015-11-02

Characterization of Baseline Biomarker Variability in Participants With Hepatocellular Carcinoma (MK-0000-215)

Phase 1 Terminated

12 enrolled 7 charts

Gastrointestinal

Carcinoma, Hepatocellular

NCT02100618 2015-07-20

Antibody Persistence for GlaxoSmithKline (GSK) Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) Administered in Healthy Adults and Adolescents, 6.5 Years After First Vaccination in the Primary Study

Phase 3 Withdrawn

Papillomavirus Infections

NCT01071837 2015-06-16

APG101 in Glioblastoma

Phase 2 Completed

Glioblastoma

NCT01329718 2014-08-04

SPR0012

Phase EARLY_PHASE1 Completed

Gastrointestinal

Colorectal Neoplasms

NCT01209013 2012-05-08

Oedisse

Phase 3 Withdrawn

Gastrointestinal

Barrett Esophagus

NCT00436189 2008-04-30

Assess Cancer in Ovarian Tumors With Biomarkers.

Phase NA Completed

Neoplasms, Ovarian Neoplasms, Arachnodactyly

NCT00140036 2008-03-03

Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV).

Phase 4 Completed

Gastrointestinal

Colorectal Neoplasms